Abstract
Green synthesis of silver nanoparticles has attained wider interest for biomedical applications owing to higher stability, and biocompatibility. Unlike the physico-chemical method, green synthesis of nanoparticles is an ecofriendly, economical and simple process. The present study aims to synthesize silver nanoparticles and evaluate its biocompatibility using radish (Raphanus sativus L.) seeds as reducing and stabilizing agent. The silver nanoparticles showed UV–vis absorption peak around 452 nm. The nanoparticles were thereafter characterized using X-ray diffractometer (XRD), Scanning electron microscopy (SEM), Transmission electron microscopy (TEM), and Energy Dispersive X-ray (EDX) analysis. The synthesized nanoparticles revealed crystalline nature, spherical shape, with size in the range of 5–20 nm and strong intense peak around 3 KeV corresponding to elemental silver. The biomolecules of seed extract enable the reduction of silver ions is revealed by specific bands in FTIR spectra. Further, blood compatibility of silver nanoparticles was ascertained using hemolysis assay which revealed non-toxic nature of AgNPs. The biocompatibility of silver nanoparticles was assessed with colon carcinoma cell line HCT-15 using cell viability assay. It showed higher cell compatibility under the safety framework. Hence, these preliminary studies suggest biocompatible properties of silver nanoparticles which is major prerequisite for its biomedical application as drug-carrier system for future cancer therapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.